Homburger advised Addex Therapeutics

Homburger advised Addex Therapeutics Ltd in connection with the global offering of 6,900,000 shares  (including 6,750,000 shares delivered in the form of 1,125,000 American Depositary Shares, or ADSs) on the Nasdaq Capital Market at a price of approximately CHF 1.47 per share or $ 10.00 per ADS, including the full exercise of the underwriter’s option to purchase additional securities. The New Shares have been listed on the SIX Swiss Exchange and the new ADS have been listed on Nasdaq.

The team

Homburger advised Addex with respect to the Swiss legal aspects of the offering. The team comprised partner Frank Gerhard (pictured), associates Karin Mattle, Guy Deillon and Lorenzo Togni and junior associate Vincent Croisier (all Corporate / M&A and Capital Markets).